Top section
Top section
Bpifrance pounces to sell Technip block after shares leap
Europe’s self-proclaimed investment banking champions are playing to their strengths, but remain far behind US peers
The most successful investment banks must strive for excellence in managing people
More articles
More articles
More articles
-
Convertible bond investors are preparing for elevated levels of volatility in the wake of the extremely close US election results, but many are waiting for more results in key states before taking a view on the direction of the market. -
Equity markets awoke on Wednesday morning to an inconclusive US presidential election where there is no clear winner between US president Donald Trump and his challenger, former vice president Joe Biden. Equity capital markets are likely to remain shut for at least the next few days as they wait to find out who has won especially as vitriol between the candidates increases.
-
Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has set the final terms for its Rp64.8bn ($866.5m) IPO in India.
-
Chinese biopharmaceutical firm RemeGen has raised HK$3.99bn ($514.7m) after pricing its IPO at the top of the marketed range, according to a source familiar with the matter.
-
The Shanghai bourse stunned the market on Tuesday after halting Ant Group’s $34bn IPO, a deal which was set to be the largest listing in history. The extraordinary move, likely spurred by comments from Ant’s co-founder Jack Ma that criticised authorities for stifling innovation in China, is expected to delay the listing by at least six months. It will also force investors to revalue the company.
-
It’s a pity the irreversible damage to our world’s lungs through the wanton destruction of its rainforests does not come with the same stark health warning found on a packet of cigarettes. If it did, the world’s largest banks and asset managers might be shamed into giving up their dirty habit.
Sub-sections
shared comment list
